Michael Frezza

2.3k total citations · 2 hit papers
15 papers, 1.9k citations indexed

About

Michael Frezza is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Michael Frezza has authored 15 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Organic Chemistry and 6 papers in Molecular Biology. Recurrent topics in Michael Frezza's work include Metal complexes synthesis and properties (9 papers), Ubiquitin and proteasome pathways (5 papers) and Synthesis of β-Lactam Compounds (3 papers). Michael Frezza is often cited by papers focused on Metal complexes synthesis and properties (9 papers), Ubiquitin and proteasome pathways (5 papers) and Synthesis of β-Lactam Compounds (3 papers). Michael Frezza collaborates with scholars based in United States, China and Italy. Michael Frezza's co-authors include Q. Ping Dou, Sara M. Schmitt, Jyoti Kanwar, S.S. Hindo, Dajena Tomco, Di Chen, Andrew M. Davenport, Vesna Milacic, Di Chen and Cláudio N. Verani and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Inorganic Chemistry.

In The Last Decade

Michael Frezza

15 papers receiving 1.9k citations

Hit Papers

Bortezomib as the First Proteasome Inhibitor Anticancer D... 2010 2026 2015 2020 2011 2010 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
    2011 640 citations Michael Frezza, Sara M. Schmitt et al. Current Cancer Drug Targets profile →
  2. Novel Metals and Metal Complexes as Platforms for Cancer Therapy
    2010 462 citations Michael Frezza, S.S. Hindo et al. Current Pharmaceutical Design profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Frezza United States 14 1.0k 847 640 192 154 15 1.9k
Sara M. Schmitt United States 14 834 0.8× 1.0k 1.2× 451 0.7× 128 0.7× 187 1.2× 20 1.9k
Gregory L. Kucera United States 32 919 0.9× 1.4k 1.6× 628 1.0× 81 0.4× 196 1.3× 73 2.7k
Maurizio Viale Italy 25 634 0.6× 607 0.7× 693 1.1× 85 0.4× 110 0.7× 116 2.1k
Ida Landini Italy 28 1.6k 1.6× 1.1k 1.3× 877 1.4× 141 0.7× 48 0.3× 49 2.9k
Jose M. Pérez Spain 20 1.4k 1.4× 564 0.7× 1.1k 1.8× 216 1.1× 74 0.5× 40 2.0k
Aram Prokop Germany 28 649 0.6× 910 1.1× 1.1k 1.7× 134 0.7× 55 0.4× 64 2.1k
Gabriella Pezzoni Italy 24 885 0.9× 913 1.1× 539 0.8× 64 0.3× 113 0.7× 45 1.9k
LR Kelland United Kingdom 21 927 0.9× 843 1.0× 425 0.7× 62 0.3× 59 0.4× 37 1.7k
David B. Lovejoy Australia 18 1.7k 1.7× 938 1.1× 1.0k 1.6× 524 2.7× 281 1.8× 25 2.9k
Paolo Lunghi Italy 27 1.0k 1.0× 1.1k 1.3× 653 1.0× 344 1.8× 465 3.0× 45 2.2k

Countries citing papers authored by Michael Frezza

Since Specialization
Citations

This map shows the geographic impact of Michael Frezza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Frezza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Frezza more than expected).

Fields of papers citing papers by Michael Frezza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Frezza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Frezza. The network helps show where Michael Frezza may publish in the future.

Co-authorship network of co-authors of Michael Frezza

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Frezza. A scholar is included among the top collaborators of Michael Frezza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Frezza. Michael Frezza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Frezza, Michael, Huanjie Yang, & Q. Ping Dou. (2011). Modulation of the tumor cell death pathway by androgen receptor in response to cytotoxic stimuli. Journal of Cellular Physiology. 226(11). 2731–2739. 13 indexed citations
2.
Frezza, Michael, et al.. (2011). Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives. Current Cancer Drug Targets. 11(3). 239–253. 640 indexed citations breakdown →
3.
Frezza, Michael, Sara M. Schmitt, & Q. Ping Dou. (2011). Targeting the Ubiquitin-Proteasome Pathway: An Emerging Concept in Cancer Therapy. Current Topics in Medicinal Chemistry. 11(23). 2888–2905. 71 indexed citations
4.
Frezza, Michael, Q. Ping Dou, Yan Xiao, et al.. (2011). In Vitro and In Vivo Antitumor Activities and DNA Binding Mode of Five Coordinated Cyclometalated Organoplatinum(II) Complexes Containing Biphosphine Ligands. Journal of Medicinal Chemistry. 54(18). 6166–6176. 71 indexed citations
5.
Jiao, Peifu, et al.. (2010). Turning Tumor-Promoting Copper into an Anti-Cancer Weapon via High-Throughput Chemistry. Current Medicinal Chemistry. 17(25). 2685–2698. 91 indexed citations
6.
Frezza, Michael, S.S. Hindo, Di Chen, et al.. (2010). Novel Metals and Metal Complexes as Platforms for Cancer Therapy. Current Pharmaceutical Design. 16(16). 1813–1825. 462 indexed citations breakdown →
7.
Hindo, S.S., Michael Frezza, Dajena Tomco, et al.. (2009). Metals in anticancer therapy: Copper(II) complexes as inhibitors of the 20S proteasome. European Journal of Medicinal Chemistry. 44(11). 4353–4361. 87 indexed citations
8.
Zhang, Xia, Michael Frezza, Vesna Milacic, et al.. (2009). Inhibition of tumor proteasome activity by gold–dithiocarbamato complexes via both redox‐dependent and ‐independent processes. Journal of Cellular Biochemistry. 109(1). 162–172. 102 indexed citations
9.
Chen, Di, Vesna Milacic, Michael Frezza, & Q. Ping Dou. (2009). Metal Complexes, their Cellular Targets and Potential for Cancer Therapy. Current Pharmaceutical Design. 15(7). 777–791. 143 indexed citations
10.
Frezza, Michael, S.S. Hindo, Dajena Tomco, et al.. (2009). Comparative Activities of Nickel(II) and Zinc(II) Complexes of Asymmetric [NN′O] Ligands as 26S Proteasome Inhibitors. Inorganic Chemistry. 48(13). 5928–5937. 59 indexed citations
11.
Chen, Di, Michael Frezza, Vesna Milacic, et al.. (2008). Anti-tumor activity of N-thiolated β-lactam antibiotics. Cancer Letters. 268(1). 63–69. 40 indexed citations
12.
Frezza, Michael, et al.. (2008). Induction of tumor cell apoptosis by a novel class of N-thiolated β-lactam antibiotics with structural modifications at N1 and C3 of the lactam ring. International Journal of Molecular Medicine. 3 indexed citations
13.
Frezza, Michael, et al.. (2008). Induction of tumor cell apoptosis by a novel class of N-thiolated beta-lactam antibiotics with structural modifications at N1 and C3 of the lactam ring.. PubMed. 21(6). 689–95. 16 indexed citations
14.
Chen, Di, Michael Frezza, R. Shakya, et al.. (2007). Inhibition of the Proteasome Activity by Gallium(III) Complexes Contributes to Their Anti–Prostate Tumor Effects. Cancer Research. 67(19). 9258–9265. 86 indexed citations
15.
Frezza, Michael, Cláudio N. Verani, Di Chen, & Q. Ping Dou. (2007). The Therapeutic Potential of Gallium-Based Complexes in Anti-Tumor Drug Design. Letters in Drug Design & Discovery. 4(5). 311–317. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara M. Schmitt Breakdown of academic impact, for papers by Gregory L. Kucera Breakdown of academic impact, for papers by Maurizio Viale Breakdown of academic impact, for papers by Ida Landini Breakdown of academic impact, for papers by Jose M. Pérez Breakdown of academic impact, for papers by Aram Prokop Breakdown of academic impact, for papers by Gabriella Pezzoni Breakdown of academic impact, for papers by LR Kelland Breakdown of academic impact, for papers by David B. Lovejoy Breakdown of academic impact, for papers by Paolo Lunghi
Rankless by CCL
2026